Daisyu Toya

935 total citations
35 papers, 739 citations indexed

About

Daisyu Toya is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Daisyu Toya has authored 35 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 13 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Hepatology. Recurrent topics in Daisyu Toya's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Diabetes Management and Research (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Daisyu Toya is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Diabetes Management and Research (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers). Daisyu Toya collaborates with scholars based in Japan and United States. Daisyu Toya's co-authors include Nobuyoshi Tanaka, Shiro Miyayama, Kazuo Notsumata, Osamu Matsui, Takeshi Mitsui, Yoshiyuki Bando, Yasuji Ryu, Masashi Yamashiro, Hideo Kanehara and Taro Takeda and has published in prestigious journals such as Diabetes Care, Diabetes Research and Clinical Practice and Journal of Vascular and Interventional Radiology.

In The Last Decade

Daisyu Toya

35 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisyu Toya Japan 15 441 294 191 154 152 35 739
Hiroaki Hazama Japan 12 241 0.5× 153 0.5× 345 1.8× 140 0.9× 84 0.6× 19 699
Wenquan Zhuang China 13 436 1.0× 233 0.8× 171 0.9× 76 0.5× 169 1.1× 30 670
Noriaki Naeshiro Japan 16 390 0.9× 177 0.6× 313 1.6× 71 0.5× 49 0.3× 25 551
Daisuke Miyaki Japan 15 381 0.9× 137 0.5× 282 1.5× 50 0.3× 48 0.3× 24 505
Atsushi Takeshita Japan 13 184 0.4× 154 0.5× 174 0.9× 34 0.2× 140 0.9× 40 580
Tokio Higaki Japan 16 451 1.0× 303 1.0× 287 1.5× 17 0.1× 122 0.8× 75 691
Shintaro Yamazaki Japan 18 501 1.1× 498 1.7× 219 1.1× 26 0.2× 186 1.2× 92 979
Raphael Mohr Germany 18 290 0.7× 176 0.6× 311 1.6× 30 0.2× 233 1.5× 70 942
Kazuhiko Fukumoto Japan 12 120 0.3× 222 0.8× 103 0.5× 53 0.3× 169 1.1× 31 576
Chih‐Yun Lin Taiwan 13 673 1.5× 265 0.9× 491 2.6× 21 0.1× 121 0.8× 33 965

Countries citing papers authored by Daisyu Toya

Since Specialization
Citations

This map shows the geographic impact of Daisyu Toya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisyu Toya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisyu Toya more than expected).

Fields of papers citing papers by Daisyu Toya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisyu Toya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisyu Toya. The network helps show where Daisyu Toya may publish in the future.

Co-authorship network of co-authors of Daisyu Toya

This figure shows the co-authorship network connecting the top 25 collaborators of Daisyu Toya. A scholar is included among the top collaborators of Daisyu Toya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisyu Toya. Daisyu Toya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bando, Yoshiyuki, et al.. (2016). Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in Japanese patients with type 2 diabetes mellitus. Journal of Clinical & Translational Endocrinology. 6. 1–7. 20 indexed citations
3.
Bando, Yoshiyuki, et al.. (2016). Chronic hyperglycemia may attenuate the serum-uric-acid-lowering effect of low-dose febuxostat in Japanese patients with type 2 diabetes mellitus. Diabetology International. 7(3). 308–313. 1 indexed citations
4.
Bando, Yoshiyuki, et al.. (2015). Efficacy and Safety of Insulin Glulisine in Intensive Insulin Therapy: Bolus Insulin Adjust Nice Control by apiDRA Study (BANDRA Study). Journal of Diabetes Mellitus. 5(1). 28–35. 1 indexed citations
5.
6.
7.
Notsumata, Kazuo, Teruyuki Ueda, Hiroyuki Watanabe, et al.. (2014). Automated risk management of HBV reactivation by encoding patients^|^apos; medical records. Kanzo. 55(2). 91–99. 3 indexed citations
8.
Bando, Yoshiyuki, et al.. (2011). Obesity may attenuate the HbA1c‐lowering effect of sitagliptin in Japanese type 2 diabetic patients. Journal of Diabetes Investigation. 3(2). 170–174. 31 indexed citations
9.
Maeno, Koji, et al.. (2011). Fluorodeoxyglucose accumulation in the left atrial appendage of a patient with paroxysmal atrial fibrillation. Journal of Cardiology Cases. 5(1). e32–e35. 1 indexed citations
10.
Miyayama, Shiro, Masashi Yamashiro, Miho Okuda, et al.. (2010). Main Bile Duct Stricture Occurring After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. CardioVascular and Interventional Radiology. 33(6). 1168–1179. 50 indexed citations
11.
Miyayama, Shiro, Masashi Yamashiro, Miho Okuda, et al.. (2010). Chemoembolization for the Treatment of Large Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 21(8). 1226–1234. 32 indexed citations
12.
Bando, Yoshiyuki, et al.. (2009). Characteristics of undiagnosed diabetes mellitus in a population undergoing health screening in Japan: Target populations for efficient screening. Diabetes Research and Clinical Practice. 83(3). 341–346. 16 indexed citations
13.
Miyayama, Shiro, Masashi Yamashiro, Taro Takeda, et al.. (2007). Acute Cholecystitis Caused by Malignant Cystic Duct Obstruction: Treatment with Metallic Stent Placement. CardioVascular and Interventional Radiology. 31(S2). 221–226. 9 indexed citations
14.
Miyayama, Shiro, Osamu Matsui, Tetsuya Minami, et al.. (2006). Bile Duct Disruption after Blunt Hepatic Trauma: Treatment with Percutaneous Repair. The Journal of Trauma: Injury, Infection, and Critical Care. 60(3). 640–643. 4 indexed citations
15.
Miyayama, Shiro, Osamu Matsui, Tetsuya Minami, et al.. (2005). Extrahepatic Blood Supply to Hepatocellular Carcinoma: Angiographic Demonstration and Transcatheter Arterial Chemoembolization. CardioVascular and Interventional Radiology. 29(1). 39–48. 113 indexed citations
16.
Miyayama, Shiro, Osamu Matsui, Tetsuya Minami, et al.. (2004). Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Fed by the Reconstructed Inferior Phrenic Artery: Anatomical and Technical Analysis. Journal of Vascular and Interventional Radiology. 15(8). 815–823. 17 indexed citations
17.
Miyayama, Shiro, Osamu Matsui, Toru Yamamoto, et al.. (2004). Efficacy of Covered Metallic Stents in the Treatment of Unresectable Malignant Biliary Obstruction. CardioVascular and Interventional Radiology. 27(4). 349–54. 13 indexed citations
18.
Miyayama, Shiro, Osamu Matsui, Tetsuya Minami, et al.. (2003). Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma Fed by the Cystic Artery. Journal of Vascular and Interventional Radiology. 14(9). 1155–1161. 40 indexed citations
19.
Miyayama, Shiro, O Matsui, Toru Yamamoto, et al.. (2001). Use of a Catheter with a Large Side Hole for Selective Catheterization of the Inferior Phrenic Artery. Journal of Vascular and Interventional Radiology. 12(4). 497–499. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroaki Hazama Breakdown of academic impact, for papers by Wenquan Zhuang Breakdown of academic impact, for papers by Noriaki Naeshiro Breakdown of academic impact, for papers by Daisuke Miyaki Breakdown of academic impact, for papers by Atsushi Takeshita Breakdown of academic impact, for papers by Tokio Higaki Breakdown of academic impact, for papers by Shintaro Yamazaki Breakdown of academic impact, for papers by Raphael Mohr Breakdown of academic impact, for papers by Kazuhiko Fukumoto Breakdown of academic impact, for papers by Chih‐Yun Lin
Rankless by CCL
2026